Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

(2011) Gianluca Rizzo et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Surgical resection in Crohn’s disease: is immunosuppressive medication associated with higher postoperative infection rates?

(2010) J. Canedo et al.   Colorectal Disease

Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders

(2010) Meghan T. Hession et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease

(2010) Basil S. Nasir et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis

(2009) Z. YANG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

(2009) M. Ferrante et al.   INFLAMMATORY BOWEL DISEASES

Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-  blockers: perioperative interruption of tumour necrosis factor-  blockers decreases complications?

(2009) K. Kawakami et al.   RHEUMATOLOGY

Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients

(2009) Adrian A. Indar et al.   WORLD JOURNAL OF SURGERY

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

(2008) I. J. Mor et al.   DISEASES OF THE COLON & RECTUM

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

(2008) Kweku A. Appau et al.   JOURNAL OF GASTROINTESTINAL SURGERY